21 Einträge gefunden

1. Determinants of costs and benefits in psoriasis routine care: results from a cross-sectional nationwide study in Germany

   1. Zander, N
   2. Naatz, M
   3. Augustin, M
   4. Langenbruch, A
   5. Topp, J
   6. Mrowietz, U
   7. von Kiedrowski, R

   2021 - Forschungsinformationssystem des UKE
2. A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE)

   1. Pinter, A
   2. Hoffmann, M
   3. Reich, K
   4. Augustin, M
   5. Kaplan, K
   6. Gudjónsdóttir, S D
   7. Delvin, T

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study

   1. Reich, K
   2. Sullivan, J
   3. Arenberger, P
   4. Jazayeri, S
   5. Mrowietz, U
   6. Augustin, M
   7. Elewski, B

   2021 - Forschungsinformationssystem des UKE
4. Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results

   1. Augustin, M
   2. Dauden, E
   3. Mrowietz, U
   4. Konstantinou, M P
   5. Gerdes, S
   6. Kingo, K
   7. Szepietowski, J C

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry study

   1. Maul, J-T
   2. Augustin, M
   3. Sorbe, C
   4. Conrad, C
   5. Anzengruber, F
   6. Mrowietz, U
   7. Reich, K

   2021 - Forschungsinformationssystem des UKE
6. Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment

   1. Leutz, A
   2. Pinter, A
   3. Thaçi, D
   4. Augustin, M
   5. Schuster, C
   6. Fotiou, K
   7. Hundemer, H P

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Perception and determinants of stigmatization of people with psoriasis in the German population

   1. Sommer, R
   2. Topp, J
   3. Mrowietz, U
   4. Zander, N
   5. Augustin, M

   2020 - Forschungsinformationssystem des UKE
8. Baseline characteristics of patients with moderate-to-severe psoriasis according to previous systemic treatment exposure: the PROSE study population

   1. Augustin, M
   2. Dauden, E
   3. Mrowietz, U
   4. Konstantinou, M P
   5. Gerdes, S
   6. Rissler, M
   7. Gathmann, S

   2020 - Forschungsinformationssystem des UKE
9. Continued treatment with secukinumab is associated with high retention or regain of response

   1. Augustin, M
   2. Thaci, D
   3. Eyerich, K
   4. Pinter, A
   5. Radtke, M
   6. Lauffer, F
   7. Mrowietz, U

   2020 - Forschungsinformationssystem des UKE
10. A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatment

    1. Reich, K
    2. Augustin, M
    3. Thaçi, D
    4. Pinter, A
    5. Leutz, A
    6. Henneges, C
    7. Schneider, E

    2020 - Forschungsinformationssystem des UKE
11. Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patients

    1. Augustin, M
    2. Sommer, R
    3. Kirsten, N
    4. Danckworth, A
    5. Radtke, M A
    6. Reich, K
    7. Thaci, D

    2019 - Forschungsinformationssystem des UKE
12. Perception of stigmatization in people with psoriasis-qualitative analysis from the perspective of patients, relatives and healthcare professionals, Stigmatisierungserleben bei Psoriasis – qualitative Analyse aus Sicht von Betroffenen, Angehörigen und Versorgern

    1. Sommer, R
    2. Augustin, M
    3. Mrowietz, U
    4. Topp, J
    5. Schäfer, I
    6. von Spreckelsen, R

    2019 - Forschungsinformationssystem des UKE
13. Strategies to reduce stigma related to visible chronic skin diseases: a systematic review

    1. Topp, J
    2. Andrees, V
    3. Weinberger, N A
    4. Schäfer, I
    5. Sommer, R
    6. Mrowietz, U
    7. Luck-Sikorski, C

    2019 - Forschungsinformationssystem des UKE
14. Translating the WHA resolution in a member state: towards a German programme on 'Destigmatization' for individuals with visible chronic skin diseases

    1. Augustin, M
    2. Mrowietz, U
    3. Luck-Sikorski, C
    4. von Kiedrowski, R
    5. Schlette, S
    6. Radtke, M A
    7. John, S M

    2019 - Forschungsinformationssystem des UKE
15. Effects of psychosocial interventions on patient-reported outcomes in patients with psoriasis: A systematic review and meta-analysis

    1. Zill, J M
    2. Christalle, E
    3. Tillenburg, N
    4. Mrowietz, U
    5. Augustin, M
    6. Härter, M
    7. Dirmaier, J

    2019 - Forschungsinformationssystem des UKE
16. Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long-term psoriasis management

    1. Augustin, M
    2. Langenbruch, A
    3. Gutknecht, M
    4. Reich, K
    5. Körber, A
    6. Maaßen, D
    7. Mrowietz, U

    2018 - Forschungsinformationssystem des UKE
17. "Schuppenflechte" or "Psoriasis"? : Wording and awareness of technical terms in the general public, „Schuppenflechte“ oder „Psoriasis“?: Wortwahl und Bekanntheit der Fachbegriffe in der Öffentlichkeit

    1. Sommer, R
    2. Mrowietz, U
    3. Zander, N
    4. Augustin, M

    2018 - Forschungsinformationssystem des UKE
18. Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic Treatments: results from the randomized controlled PRIME trial

    1. Sticherling, M
    2. Mrowietz, U
    3. Augustin, M
    4. Thaçi, D
    5. Melzer, N
    6. Hentschke, C
    7. Kneidl, J

    2017 - Forschungsinformationssystem des UKE
19. Continuous Dosing Versus Interrupted Therapy with Ixekizumab: An Integrated Analysis of Two Phase 3 Trials in Psoriasis

    1. Blauvelt, Andrew
    2. Papp, K A
    3. Sofen, H L
    4. Augustin, M
    5. Yosipovitch, Gil
    6. Katoh, N
    7. Mrowietz, U

    2017 - Forschungsinformationssystem des UKE
20. The German National Program on Psoriasis Health Care 2005-2015: Results and Experiences

    1. Augustin, M
    2. Eissing, L
    3. Langenbruch, A
    4. Enk, A
    5. Luger, T
    6. Maaßen, D
    7. Mrowietz, U

    2016 - Forschungsinformationssystem des UKE